Showing results (81-90 of 113) with videos related to
Sort By:
Pageof 12
Transplantation Direct|October 8, 2025
Tocilizumab Treatment for Microvascular Inflammation and Chronic Active Antibody-mediated Rejection in Kidney TransplantationEdmund Huang, Michie Adjei, Alice Peng, et al.Cornea|December 8, 2021
Dysbiosis of Ocular Surface Microbiota in Patients With Refractive Allergic Conjunctival DiseasesNoriko Inada, Jun Shoji, Gaku Harata, et al.Ophthalmic Genetics|December 2, 2024
Unilateral lattice corneal dystrophy with c.1501C>A (p.P501T) and c.1733T>C (p.L578P) variants in the transforming growth factor-beta induced gene: a case reportRumi Adachi, Jun Shoji, Kentaro Yuda, et al.Journal of Clinical Medicine|August 29, 2024
Subjective Symptoms and Disease Activity Related to Serum Zinc Concentration in Primary Sjögren's SyndromeKumiko Akiya, Masahiro Nishihara, Yosuke Nagasawa, et al.Allergology International : Official Journal of the Japanese Society of Allergology|July 14, 2020
Epidemiological aspects of allergic conjunctivitisDai Miyazaki, Kazumi Fukagawa, Shigeki Okamoto, et al.Current Eye Research|January 17, 2018
Clinical Severity Classification using Automated Conjunctival Hyperemia Analysis Software in Patients with Superior Limbic KeratoconjunctivitisJunki Kurita, Jun Shoji, Noriko Inada, et al.Plos One|April 16, 2015
Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathyMegumi Morita, Akiko Mii, Akira Shimizu, et al.Current Eye Research|April 6, 2019
Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic DermatitisJun Shoji, Yuichi Ohashi, Atsuki Fukushima, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|May 16, 2009
A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitisNobuyuki Ebihara, Yuichi Ohashi, Eiichi Uchio, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 24, 2010
A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitisYuichi Ohashi, Nobuyuki Ebihara, Hiroshi Fujishima, et al.Pageof 12